NM_001130475.3:c.*1710G>A
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001130475.3(THAP5):c.*1710G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.291 in 152,010 control chromosomes in the GnomAD database, including 6,793 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001130475.3 3_prime_UTR
Scores
Clinical Significance
Conservation
Publications
- mitochondrial myopathy-lactic acidosis-deafness syndromeInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001130475.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Frequencies
GnomAD3 genomes AF: 0.291 AC: 44193AN: 151890Hom.: 6793 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.500 AC: 1AN: 2Hom.: 0 Cov.: 0 AF XY: 0.500 AC XY: 1AN XY: 2 show subpopulations
GnomAD4 genome AF: 0.291 AC: 44193AN: 152008Hom.: 6793 Cov.: 32 AF XY: 0.283 AC XY: 21048AN XY: 74286 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at